OGN vs. ABT
Compare and contrast key facts about Organon & Co. (OGN) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OGN or ABT.
Correlation
The correlation between OGN and ABT is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
OGN vs. ABT - Performance Comparison
Key characteristics
OGN:
0.14
ABT:
0.09
OGN:
0.48
ABT:
0.26
OGN:
1.06
ABT:
1.03
OGN:
0.09
ABT:
0.06
OGN:
0.31
ABT:
0.20
OGN:
16.89%
ABT:
8.15%
OGN:
35.68%
ABT:
18.10%
OGN:
-69.56%
ABT:
-45.66%
OGN:
-53.52%
ABT:
-14.69%
Fundamentals
OGN:
$4.17B
ABT:
$196.83B
OGN:
$4.91
ABT:
$3.29
OGN:
3.21
ABT:
34.49
OGN:
$4.81B
ABT:
$30.98B
OGN:
$2.82B
ABT:
$17.29B
OGN:
$1.31B
ABT:
$7.89B
Returns By Period
In the year-to-date period, OGN achieves a 5.50% return, which is significantly higher than ABT's 0.85% return.
OGN
5.50%
8.48%
-22.57%
6.58%
N/A
N/A
ABT
0.85%
1.47%
12.34%
0.97%
6.87%
12.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OGN vs. ABT — Risk-Adjusted Performance Rank
OGN
ABT
OGN vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
OGN vs. ABT - Dividend Comparison
OGN's dividend yield for the trailing twelve months is around 7.12%, more than ABT's 1.97% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OGN Organon & Co. | 7.12% | 7.51% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABT Abbott Laboratories | 1.97% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
OGN vs. ABT - Drawdown Comparison
The maximum OGN drawdown since its inception was -69.56%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for OGN and ABT. For additional features, visit the drawdowns tool.
Volatility
OGN vs. ABT - Volatility Comparison
Organon & Co. (OGN) has a higher volatility of 7.45% compared to Abbott Laboratories (ABT) at 4.74%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
OGN vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Organon & Co. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities